3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide

C47H65N5O12 — CID 168897402

IUPAC3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide
SMILESCCc1c(C)c2cc3[nH]c(cc4nc(c(C)c5nc(cc1[nH]2)C(C)=C5)[C@@H](CCC(=O)N(C)CCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]4C)c(C)c3CO[C@H]1C[C@@H](O)[C@H](O)[C@@H](CO)O1
InChIInChI=1S/C47H65N5O12/c1-8-27-23(3)33-17-36-29(21-62-41-18-37(55)43(57)38(19-53)63-41)25(5)32(50-36)16-34-24(4)28(42(51-34)26(6)31-14-22(2)30(48-31)15-35(27)49-33)10-11-40(56)52(7)12-9-13-61-47-46(60)45(59)44(58)39(20-54)64-47/h14-17,24,28,37-39,41,43-47,49-50,53-55,57-60H,8-13,18-21H2,1-7H3/b30-15-,31-26-,32-16-,33-17-,34-16-,35-15-,36-17-,42-26-/t24-,28-,37+,38+,39+,41+,43-,44+,45-,46+,47+/m0/s1
InChIKeyPSSYRXWDFOPOAF-MAEPFOIWSA-N
MW892.06 g/mol
LogP3.04
Rot. Bonds14

About 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide

3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide (PubChem CID 168897402) has the molecular formula C47H65N5O12 and a molecular weight of 892.06 g/mol. Its IUPAC name is 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide.

Molecular Properties

Compound Name3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide
PubChem CID168897402
Molecular FormulaC47H65N5O12
Molecular Weight892.06 g/mol
Exact Mass891.46
IUPAC Name3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide
SMILESCCc1c(C)c2cc3[nH]c(cc4nc(c(C)c5nc(cc1[nH]2)C(C)=C5)[C@@H](CCC(=O)N(C)CCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]4C)c(C)c3CO[C@H]1C[C@@H](O)[C@H](O)[C@@H](CO)O1
InChIInChI=1S/C47H65N5O12/c1-8-27-23(3)33-17-36-29(21-62-41-18-37(55)43(57)38(19-53)63-41)25(5)32(50-36)16-34-24(4)28(42(51-34)26(6)31-14-22(2)30(48-31)15-35(27)49-33)10-11-40(56)52(7)12-9-13-61-47-46(60)45(59)44(58)39(20-54)64-47/h14-17,24,28,37-39,41,43-47,49-50,53-55,57-60H,8-13,18-21H2,1-7H3/b30-15-,31-26-,32-16-,33-17-,34-16-,35-15-,36-17-,42-26-/t24-,28-,37+,38+,39+,41+,43-,44+,45-,46+,47+/m0/s1
InChIKeyPSSYRXWDFOPOAF-MAEPFOIWSA-N
XLogP3.04
TPSA256.20 Ų
H-Bond Donors9
H-Bond Acceptors14
Rotatable Bonds14
Heavy Atoms64
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500892.06
LogP ≤ 53.04
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide?
The IUPAC name of 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide (CID 168897402) is 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide.
What is the SMILES notation for 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide?
The canonical SMILES for 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide is CCc1c(C)c2cc3[nH]c(cc4nc(c(C)c5nc(cc1[nH]2)C(C)=C5)[C@@H](CCC(=O)N(C)CCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]4C)c(C)c3CO[C@H]1C[C@@H](O)[C@H](O)[C@@H](CO)O1.
What is the InChIKey of 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide?
The InChIKey is PSSYRXWDFOPOAF-MAEPFOIWSA-N. The full InChI is InChI=1S/C47H65N5O12/c1-8-27-23(3)33-17-36-29(21-62-41-18-37(55)43(57)38(19-53)63-41)25(5)32(50-36)16-34-24(4)28(42(51-34)26(6)31-14-22(2)30(48-31)15-35(27)49-33)10-11-40(56)52(7)12-9-13-61-47-46(60)45(59)44(58)39(20-54)64-47/h14-17,24,28,37-39,41,43-47,49-50,53-55,57-60H,8-13,18-21H2,1-7H3/b30-15-,31-26-,32-16-,33-17-,34-16-,35-15-,36-17-,42-26-/t24-,28-,37+,38+,39+,41+,43-,44+,45-,46+,47+/m0/s1.
What are the key properties of 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide?
3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide has a molecular weight of 892.06 g/mol, XLogP of 3.04, 14 rotatable bonds, 9 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(2S,3S)-8-[[(2R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-13-ethyl-3,7,12,17,20-pentamethyl-2,3,22,23-tetrahydroporphyrin-2-yl]-N-methyl-N-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl]propanamide is sourced from PubChem (CID 168897402), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).